Literature DB >> 9224620

Identification of an intronic enhancer that nullifies upstream repression of SPARC gene expression.

K Satyamoorthy1, S J Samulewicz, L D Thornburg, A Basu, C C Howe.   

Abstract

The SPARC gene 5'flanking sequence has been shown to contain enhancer elements, but also negative control elements immediately upstream of the enhancer elements. Although these 5'enhancer elements are active in F9 and PYS-2 cells, their activities are nullified by the 5'repressor activity. In the present study we have identified within intron 1 between nucleotides (nt) +5000 and +5150 of the SPARC gene an enhancer element that bound to two transcription factors of 48 and 52 kDa and between nt +5000 and +5523 a DNase I hypersensitive site. Furthermore, a region containing the 3'intron 1 enhancer element, together with the 5'enhancer elements, neutralized the 5'repressor activity and stimulated efficient transcription. The resulting SPARC promoter activity is about equal in F9, differentiated F9 and PYS-2 cells. We consistently found that the rate of SPARC transcription is nearly the same in F9 and PYS-2 cells. Association of the 3'enhancer element in intron 1 with the DNase I hypersensitive site suggests that both play a role in regulating SPARC expression in vivo .

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224620      PMCID: PMC146837          DOI: 10.1093/nar/25.15.3169

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  27 in total

1.  Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo.

Authors:  M L Iruela-Arispe; T F Lane; D Redmond; M Reilly; R P Bolender; T J Kavanagh; E H Sage
Journal:  Mol Biol Cell       Date:  1995-03       Impact factor: 4.138

2.  Antisense transcripts and protein binding motifs within the Wilms tumour (WT1) locus.

Authors:  C E Campbell; A Huang; A L Gurney; P M Kessler; J A Hewitt; B R Williams
Journal:  Oncogene       Date:  1994-02       Impact factor: 9.867

3.  Selective isolation of cosmid clones by homologous recombination in Escherichia coli.

Authors:  A Poustka; H R Rackwitz; A M Frischauf; B Hohn; H Lehrach
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

4.  Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP.

Authors:  S Strickland; K K Smith; K R Marotti
Journal:  Cell       Date:  1980-09       Impact factor: 41.582

5.  A purine-rich sequence in the human BM-40 gene promoter region is a prerequisite for maximum transcription.

Authors:  M Hafner; K Zimmermann; J Pottgiesser; T Krieg; R Nischt
Journal:  Matrix Biol       Date:  1995-12       Impact factor: 11.583

6.  SPARC is a source of copper-binding peptides that stimulate angiogenesis.

Authors:  T F Lane; M L Iruela-Arispe; R S Johnson; E H Sage
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

7.  Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization.

Authors:  M J Reed; P Puolakkainen; T F Lane; D Dickerson; P Bornstein; E H Sage
Journal:  J Histochem Cytochem       Date:  1993-10       Impact factor: 2.479

8.  Expression of the intracisternal A-particle is elevated during differentiation of embryonal carcinoma cells.

Authors:  C C Howe; G C Overton
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

9.  Transcription of the human beta enolase gene (ENO-3) is regulated by an intronic muscle-specific enhancer that binds myocyte-specific enhancer factor 2 proteins and ubiquitous G-rich-box binding factors.

Authors:  S Feo; V Antona; G Barbieri; R Passantino; L Calì; A Giallongo
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

10.  Developmental and transformation-sensitive expression of the Sparc gene on mouse chromosome 11.

Authors:  I J Mason; D Murphy; M Münke; U Francke; R W Elliott; B L Hogan
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.